dc.contributor.advisor | 2018. The authors | |
dc.contributor.author | Schliephake, H | en_US |
dc.contributor.author | Sicilia, A | en_US |
dc.contributor.author | Al Nawas, B | en_US |
dc.contributor.author | Donos, N | en_US |
dc.contributor.author | Gruber, R | en_US |
dc.contributor.author | Jepsen, S | en_US |
dc.contributor.author | Milinkovic, I | en_US |
dc.contributor.author | Mombelli, A | en_US |
dc.contributor.author | Navarro, JM | en_US |
dc.contributor.author | Quirynen, M | en_US |
dc.contributor.author | Rocchietta, I | en_US |
dc.contributor.author | Schiodt, M | en_US |
dc.contributor.author | Schou, S | en_US |
dc.contributor.author | Stahli, A | en_US |
dc.contributor.author | Stavropoulos, A | en_US |
dc.date.accessioned | 2019-04-18T15:19:02Z | |
dc.date.available | 2018-04-24 | en_US |
dc.date.issued | 2018-10 | en_US |
dc.identifier.issn | 0905-7161 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/56920 | |
dc.description | This is the peer reviewed version of the following article: Schliephake, H., et al. (2018). "Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018." Clinical Oral Implants Research 29(S18): 93-99., which has been published in final form at DOI: 10.1111/clr.13270. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | en_US |
dc.format.extent | 93 - 99 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | CLINICAL ORAL IMPLANTS RESEARCH | en_US |
dc.rights | CC-NC | |
dc.rights | Attribution-NonCommercial 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/us/ | * |
dc.subject | alveolar ridge preservation | en_US |
dc.subject | antiresorptive drugs | en_US |
dc.subject | bisphosphonates | en_US |
dc.subject | corrosion | en_US |
dc.subject | dental implants | en_US |
dc.subject | guided bone regeneration sinus floor elevation | en_US |
dc.subject | hormone replacement therapy | en_US |
dc.subject | implant therapy | en_US |
dc.subject | medication-related osteonecrosis of the jaws | en_US |
dc.subject | peri-implantitis | en_US |
dc.subject | platelet-rich fibrin | en_US |
dc.subject | platelet-rich plasma | en_US |
dc.subject | systematic review | en_US |
dc.subject | titanium | en_US |
dc.title | Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018 | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1111/clr.13270 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446982400006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 29 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |